A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
St. Jude Children's Research Hospital
USWM, LLC (dba US WorldMeds)
Hackensack Meridian Health
Hackensack Meridian Health
Stanford University
Baylor College of Medicine
Gilead Sciences
Gilead Sciences
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Hoffmann-La Roche
Allogene Therapeutics
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Dartmouth-Hitchcock Medical Center
Dana-Farber Cancer Institute
Astellas Pharma Inc
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
Medical College of Wisconsin
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Weill Medical College of Cornell University
Astellas Pharma Inc
Gilead Sciences
UNC Lineberger Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
H. Lee Moffitt Cancer Center and Research Institute
Astellas Pharma Inc
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Gilead Sciences
St. Jude Children's Research Hospital
Dana-Farber Cancer Institute
Therapeutic Advances in Childhood Leukemia Consortium
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
Sanofi
Weill Medical College of Cornell University
Affimed GmbH
Center for International Blood and Marrow Transplant Research
Gilead Sciences
Masonic Cancer Center, University of Minnesota